Antiplatelet and Antithrombotic Properties of 2-Geranyl-2',3,4,4'-tetrahydroxydihydrochalcone, A Chalcone from Artocarpus altilis (Park.) Fosberg Leaves
Main Article Content
Abstract
Thrombosis is a major contributor to the pathophysiology of cardiovascular diseases. The involvement of platelets in the formation of thrombus has been studied extensively. Platelet aggregation inhibition is a promising strategy for the treatment of thrombosis. Artocarpus altilis is a medicinal plant containing 2-geranyl-2',3,4,4'-tetrahydroxydihydrochalcone (GTDC) with antiplatelet activity. A previous study showed that the plant extract and GTDC demonstrated antiplatelet activity in ADP-induced platelet aggregation. However, no data are available regarding its efficacy in platelet aggregation induced by other agonists. In addition, the antithrombotic activity of GTDC is unknown. This study evaluates the antithrombotic activity of GTDC and determines the antiplatelet specificity action of GTDC. Antithrombotic activity assay was done using FeCl3-induced arterial thrombosis in rats, whereas the antiplatelet assays were performed in vitro utilizing human platelet induced by several platelet receptor agonists. One-way ANOVA followed by the Tukey post-hoc test (p = 95%) in GraphPad Prism 8 software were used to analyze the data statistically. We found that GTDC (30 and 60 mg/kg) demonstrated antithrombotic activity by prolonging occlusion time due to thrombosis. GTDC showed its highest selectivity in the platelet aggregation pathway induced by ADP compared with thrombin, arachidonic acid, and epinephrine.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
1. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, Elkind MSV, Evenson KR, Ferguson JF, Gupta DK, Khan SS, Kissela BM, Knutson KL, Lee CD, Lewis TT, Liu JL, Loop MS, Lutsey P, Ma J, Mackey J, Martin SS, Matchar DB, Mussolino ME, Navaneethan SD, Perak AM, Roth GA, Samad Z, Satou GM, Schroeder EB, Shah SH, Shay CM, Stokes A, VanWagner LB, Wang NY, Tsaoet CW. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143(8):e254-e743.
2. WHO. Cardiovascular diseases (CVDs) Geneva, Switzerland WHO; 2021 [Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
3. Periayah MH, Halim AS, Mat Saad AZ. Mechanism Action of Platelets and Crucial Blood Coagulation Pathways in Hemostasis. Int J Hematol Oncol Stem Cell Res. 2017;11(4):319-327.
4. Flora GD, Nayak MK. A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes. Curr Pharm Des. 2019;25(38):4063-4084.
5. Alkarithi G, Duval C, Shi Y, Macrae FL, Ariëns RAS. Thrombus Structural Composition in Cardiovascular Disease. Arterioscler Thromb Vasc Biol. 2021;41(9):2370-2383.
6. Rivera J, Lozano ML, Navarro-Nunez L, Vicente V. Platelet receptors and signaling in the dynamics of thrombus formation. Haematol. 2009;94(5):700-711.
7. Montague SJ, Andrews RK, Gardiner EE. Mechanisms of receptor shedding in platelets. Blood. 2018;132(24):2535-2545.
8. Packham MA. Role of platelets in thrombosis and hemostasis. Can J Physiol Pharmacol. 1994;72(3):278-284.
9. Wang Y, Andrews M, Yang Y, Lang S, Jin JW, Cameron-Vendrig A, Zhu G, Reheman A, Niet H, Platelets in thrombosis and hemostasis: old topic with new mechanisms. Cardiovasc Hematol Disord Drug Targets. 2012;12(2):126-132.
10. Koupenova M, Ravid K. Biology of Platelet Purinergic Receptors and Implications for Platelet Heterogeneity. Front Pharmacol. 2018;9(37):1-9.
11. Yeung J, Li W, Holinstat M. Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases. Pharmacol Rev. 2018;70(3):526-548.
12. Mackman N, Bergmeier W, Stouffer GA, Weitz JI. Therapeutic strategies for thrombosis: new targets and approaches. Nat. Rev. Drug Discov. 2020;19(5):333-352.
13. Herlyanti K, Murwanti R, Wahyono, Fakhrudin N. Antiplatelet Activity of Piper cubeba Fruit Ethanol Extract. Trop J Nat Prod Res. 2022;6(11):1832-1835.
14. Herlyanti K, Fakhrudin N, Murwanti R, Wahyono. Identification of Cubebin from Cubeb (Piper cubeba) as An Antiplatelet Agent. Trop J Nat Prod Res. 2023;7(7):3392-3397.
15. Wang Y, Deng T, Lin L, Pan Y, Zheng X. Bioassay-guided isolation of antiatherosclerotic phytochemicals from Artocarpus altilis. Phytother Res. 2006;20(12):1052-1055.
16. Fajaryanti N, Nurrochmad A, Fakhrudin N. Evaluation of antihyperlipidemic activity and total flavonoid content of Artocarpus altilis leaves extracts. Int J Pharm Clin Res. 2016;8(5):461-465.
17. Fakhrudin N, Khairunnisa SY, Azzahra A, Ajiningtyas RJ. Study of radical scavenger activity, total phenol and flavonoid contents of Artocarpus altilis leaves extracts. Int J Pharm Clin Res. 2016;8(5):352-356.
18. Fakhrudin N, Pertiwi KK, Takubessi MI, Susiani EF, Nurrochmad A, Widyarini S, Sudarmanto A, Nugroho AA, Wahyuono S, A geranylated chalcone with antiplatelet activity from the leaves of breadfruit (Artocarpus altilis). Pharmacia. 2020;67(4):173-180.
19. Cattaneo M. P2Y12 receptors: structure and function. J Thromb Haemost. 2015;13(S1):S10-S16.
20. Born GVR, and Cross MJ. The aggregation of blood platelets. J Physiol. 1963;168(1):178-195.
21. Fakhrudin N, Wiyono T, Putra AR, Nurrochmad A, Widyarini S. The evaluation on anti-platelet and antithrombosis activities of Cinnamomum sintoc bark extract. Thai J. Pharm. Sci. 2019;43(4):219-226.
22. Misra A, Prakash P, Aggarwal H, Dhankani P, Kumar S, Pandey CP, Pugh N, Bihan D, Barthwal MK, Farndale RW, Dikshit DK, Dikshit M. Anti-thrombotic efficacy of S007-867: Pre-clinical evaluation in experimental models of thrombosis in vivo and in vitro. Biochem Pharmacol. 2018;148:288-297.
23. Capodanno D, Dharmashankar K, Angiolillo DJ. Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y12 receptor antagonist. Expert Rev Cardiovasc Ther. 2010;8(2):151-158.
24. Weng J-R, Chan S-C, Lu Y-H, Lin H-C, Ko H-H, Lin C-N. Antiplatelet prenylflavonoids from Artocarpus communis. Phytochem. 2006;67:824-829.
25. Corkrey HA, Koupenova M, Freedman JE, Kehrel BE. Thrombosis and platelets: an update. Eur Heart J. 2016;38(11):785-791.
26. Li W, McIntyre TM, Silverstein RL. Ferric chloride-induced murine carotid arterial injury: A model of redox pathology. Redox Biol. 2013;1(1):50-55.
27. Polak D, Talar M, Watala C, Przygodzki T. Intravital Assessment of Blood Platelet Function. A Review of the Methodological Approaches with Examples of Studies of Selected Aspects of Blood Platelet Function. Int J Mol Sci. 2020;21(21).
28. Fakhrudin N, Hastuti S, Andriani A, Widyarini S, Nurrochmad A. Study on the antiinflammatory activity of Artocarpus altilis leaves extract in mice. Int J Pharmacogn Phytochem Res. 2015;7(6):1080-1085.